• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON BD PHASEAL¿ SECONDARY SET C61; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON BD PHASEAL¿ SECONDARY SET C61; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515302
Device Problems Delivered as Unsterile Product (1421); Unsealed Device Packaging (1444); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/19/2022
Event Type  malfunction  
Manufacturer Narrative
The manufacturing location for this product is cazin, bosnia.(b)(4).Date of event: unknown.The date received by manufacturer has been used for this field.Initial reporter e-mail: unknown a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that 3 bd phaseal¿ secondary sets c61 had damaged tubing that was sliced open through the packaging.The following information was provided by the initial reporter: "3 units of c61 were sliced due to packaging error.".
 
Event Description
It was reported that 3 bd phaseal¿ secondary sets c61 had damaged tubing that was sliced open through the packaging.The following information was provided by the initial reporter: "3 units of c61 were sliced due to packaging error.".
 
Manufacturer Narrative
H6: investigation summary: a device history review was conducted for lot number 1022262.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.During examination of retain samples, no defect has been noticed.Sample have no issues.Additionally a photograph was provided which displayed a sealed empty packaging unit.The issue has been confirmed.Based on the image our engineers were able to directly associated this issue with the manual packaging process.To prevent future occurrences the appropriate personnel have been notified of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ SECONDARY SET C61
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15580808
MDR Text Key307082342
Report Number2243072-2022-01753
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00382905153020
UDI-Public(01)00382905153020
Combination Product (y/n)N
Reporter Country CodeMY
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number515302
Device Lot Number1022262
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/15/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/19/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-